MedPath

PENNINGTON BIOMEDICAL RESEARCH CENTER

PENNINGTON BIOMEDICAL RESEARCH CENTER logo
🇺🇸United States
Ownership
Private
Established
1988-01-01
Employees
251
Market Cap
-
Website
http://www.pbrc.edu

Clinical Trials

270

Active:15
Completed:194

Trial Phases

6 Phases

Early Phase 1:6
Phase 1:10
Phase 2:5
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (179 trials with phase data)• Click on a phase to view related trials

Not Applicable
147 (82.1%)
Phase 1
10 (5.6%)
Phase 4
10 (5.6%)
Early Phase 1
6 (3.4%)
Phase 2
5 (2.8%)
Phase 3
1 (0.6%)

Continuous Glucose Monitoring in Metabolic Surgery

Not Applicable
Not yet recruiting
Conditions
Diabetes
Obesity (Disorder)
First Posted Date
2025-07-31
Last Posted Date
2025-08-03
Lead Sponsor
Pennington Biomedical Research Center
Target Recruit Count
20
Registration Number
NCT07095972
Locations
🇺🇸

Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants

Recruiting
Conditions
Infant Body Composition and Metabolism
Metabolism
Energy Expenditure
Infant Formula
Human Milk, Breast Milk
Metabolic Flexibility
First Posted Date
2025-07-31
Last Posted Date
2025-07-31
Lead Sponsor
Pennington Biomedical Research Center
Target Recruit Count
40
Registration Number
NCT07096011
Locations
🇺🇸

Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

Multicomponent Program for Addressing Cognition in Rural Communities

Not Applicable
Active, not recruiting
Conditions
Cognitive Decline
First Posted Date
2025-06-13
Last Posted Date
2025-06-13
Lead Sponsor
Pennington Biomedical Research Center
Target Recruit Count
11
Registration Number
NCT07018830
Locations
🇺🇸

Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

Impact of Lean Pork on Endothelial Function in Perimenopause

Not Applicable
Recruiting
Conditions
Cardiovascular Outcome
Perimenopausal Women
Vasomotor Symptoms (VMS)
Overweight and Obese Women
First Posted Date
2025-05-16
Last Posted Date
2025-06-22
Lead Sponsor
Pennington Biomedical Research Center
Target Recruit Count
30
Registration Number
NCT06976112
Locations
🇺🇸

Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

Iron Absorption From Lipid-Based Nutrient Supplements

Active, not recruiting
Conditions
Undernutrition
Healthy
First Posted Date
2025-03-11
Last Posted Date
2025-06-25
Lead Sponsor
Pennington Biomedical Research Center
Target Recruit Count
30
Registration Number
NCT06870201
Locations
🇰🇪

Msambweni County Referral Hospital, Msambweni, Kenya

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 54
  • Next

News

Answer ALS Launches AI-Powered Drug Discovery Initiative to Accelerate ALS Treatment Development

Answer ALS has launched LADDIA, a groundbreaking AI-powered drug discovery collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane University to accelerate ALS treatment development.

Physical Activity Significantly Improves Survival Outcomes in Stage III Colon Cancer Patients

New research reveals that stage III colon cancer patients who engage in high levels of physical activity (≥18.0 MET-hours/week) show survival rates comparable to the general population.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.